Rivastigmine Study in Adolescents With Down Syndrome
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if short term use of rivastigmine can improve
functional abilities (for example, language, memory, and executive function) in adolescents
with Down syndrome.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Duke University
Collaborators:
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Taishoff Family Foundation